Dan Leonard
Stock Analyst at UBS
(3.72)
# 654
Out of 5,182 analysts
295
Total ratings
50.84%
Success rate
7.01%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $180 → $165 | $121.87 | +35.39% | 24 | Feb 26, 2026 | |
| RGEN Repligen | Maintains: Buy | $200 → $195 | $131.21 | +48.62% | 2 | Feb 25, 2026 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $170 → $175 | $183.88 | -4.83% | 7 | Feb 25, 2026 | |
| TXG 10x Genomics | Maintains: Neutral | $14 → $20 | $26.08 | -23.31% | 8 | Feb 20, 2026 | |
| WAT Waters | Maintains: Neutral | $395 → $370 | $327.77 | +12.88% | 13 | Feb 10, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $280 → $240 | $176.46 | +36.01% | 19 | Feb 6, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $70 → $79 | $59.23 | +33.38% | 13 | Feb 5, 2026 | |
| BRKR Bruker | Maintains: Neutral | $40 → $43 | $40.70 | +5.65% | 12 | Nov 4, 2025 | |
| GH Guardant Health | Maintains: Buy | $80 → $110 | $90.36 | +21.74% | 11 | Oct 30, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $500 → $590 | $526.60 | +12.04% | 18 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $6.22 | +141.16% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $300 → $305 | $520.60 | -41.41% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $225 | $194.75 | +15.53% | 18 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1,530 → $1,350 | $1,340.58 | +0.70% | 9 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $299.02 | +3.67% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $300.23 | +3.26% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $145 → $115 | $93.96 | +22.39% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $122 → $99 | $103.54 | -4.38% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $8.52 | +193.43% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $10.35 | -13.04% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $16.25 | +115.38% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $134.50 | +48.70% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $3.39 | +224.48% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $208.40 | -66.41% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $14.47 | -51.62% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $119.68 | +117.25% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $195.02 | -25.65% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $59 → $61 | $41.24 | +46.99% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $270.68 | +25.61% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $15.53 | +54.54% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $5.08 | +588.98% | 12 | Aug 14, 2019 |
Agilent Technologies
Feb 26, 2026
Maintains: Buy
Price Target: $180 → $165
Current: $121.87
Upside: +35.39%
Repligen
Feb 25, 2026
Maintains: Buy
Price Target: $200 → $195
Current: $131.21
Upside: +48.62%
Charles River Laboratories International
Feb 25, 2026
Maintains: Neutral
Price Target: $170 → $175
Current: $183.88
Upside: -4.83%
10x Genomics
Feb 20, 2026
Maintains: Neutral
Price Target: $14 → $20
Current: $26.08
Upside: -23.31%
Waters
Feb 10, 2026
Maintains: Neutral
Price Target: $395 → $370
Current: $327.77
Upside: +12.88%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $280 → $240
Current: $176.46
Upside: +36.01%
Bio-Techne
Feb 5, 2026
Maintains: Buy
Price Target: $70 → $79
Current: $59.23
Upside: +33.38%
Bruker
Nov 4, 2025
Maintains: Neutral
Price Target: $40 → $43
Current: $40.70
Upside: +5.65%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $80 → $110
Current: $90.36
Upside: +21.74%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Neutral
Price Target: $500 → $590
Current: $526.60
Upside: +12.04%
Aug 7, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $6.22
Upside: +141.16%
Jul 29, 2025
Downgrades: Sell
Price Target: $300 → $305
Current: $520.60
Upside: -41.41%
Jul 23, 2025
Maintains: Buy
Price Target: $240 → $225
Current: $194.75
Upside: +15.53%
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,340.58
Upside: +0.70%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $299.02
Upside: +3.67%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $300.23
Upside: +3.26%
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $93.96
Upside: +22.39%
Apr 7, 2025
Maintains: Overweight
Price Target: $122 → $99
Current: $103.54
Upside: -4.38%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $8.52
Upside: +193.43%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $10.35
Upside: -13.04%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $16.25
Upside: +115.38%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $134.50
Upside: +48.70%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $3.39
Upside: +224.48%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $208.40
Upside: -66.41%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $14.47
Upside: -51.62%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $119.68
Upside: +117.25%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $195.02
Upside: -25.65%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $59 → $61
Current: $41.24
Upside: +46.99%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $270.68
Upside: +25.61%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $15.53
Upside: +54.54%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $5.08
Upside: +588.98%